RMD
ResMed Inc.NYSEHealthcare$224.09+0.56%ClosedMarket Cap: $32.71B
As of 2026-04-06
Valuation
P/E (TTM)
22.01
PEG
1.16
P/B
5.19
P/S
6.06
EV/EBITDA
15.59
DCF Value
$287.84
FCF Yield
5.5%
Div Yield
1.0%
Margins & Returns
Gross Margin
61.0%
Operating Margin
33.8%
Net Margin
27.5%
ROE
24.8%
ROA
29.5%
ROIC
19.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $1.42B | 62.2% | $497.6M | $392.6M | $2.68 | $0.60 |
| Q1 2026 | $1.34B | 61.5% | $446.5M | $348.5M | $2.37 | $0.60 |
| Q4 2025 | $1.35B | 60.8% | $454.5M | $379.7M | $2.58 | $0.53 |
| FY 2025 | $5.15B | 59.4% | $1.69B | $1.40B | $9.51 | $2.12 |
| Q3 2025 | $1.29B | 59.3% | $426.3M | $365.0M | $2.48 | $0.53 |
| Q2 2025 | $1.28B | 58.6% | $417.2M | $344.6M | $2.34 | $0.53 |
| Q1 2025 | $1.22B | 58.6% | $387.3M | $311.4M | $2.11 | $0.53 |
| Q4 2024 | $1.22B | 57.6% | $381.2M | $292.2M | $1.98 | $0.48 |
| FY 2024 | $4.69B | 56.7% | $1.32B | $1.02B | $6.92 | $1.92 |
| Q3 2024 | $1.20B | 56.9% | $374.6M | $300.5M | $2.04 | $0.48 |
| Q2 2024 | $1.16B | 57.6% | $275.1M | $208.8M | $1.42 | $0.48 |
| Q1 2024 | $1.10B | 54.4% | $289.0M | $219.4M | $1.49 | $0.48 |